Schedule 13G ownership disclosure
Edesa Biotech, Inc.
Security class unavailable · CUSIP: 27966L108
Event date: 2022-12-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,777,776
- Percent of class
- 8.7800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-23-000125
- Form type
- SC 13G
- Filer
- Edesa Biotech, Inc.
- CIK
- CIK 1540159
- Filed
- Jan 06, 2023
- Reporting period
- Dec 23, 2022
- Description
- Schedule 13G beneficial ownership